Iain is CSO of Quench Bio and an Entrepreneur-in-Residence at Atlas Venture. Prior to joining Quench he served as VP Preclinical Biology in the Inflammation and Immunology Research Unit at Pfizer where he was responsible for a portfolio of both small and large molecule programs targeted across rheumatology, dermatology and gastroenterology. Iain had a 22 year tenure at Pfizer, starting as an internal industrial postdoc and taking on roles of increasing responsibility working across the drug discovery paradigm from target identification to leading the early clinical cluster in Rheumatology and Dermatology. Iain graduated with a BA and MA Cantab in Biochemistry from Jesus College, University of Cambridge before completing his PhD in the Breast Cancer Research Laboratories at the University of Liverpool. Outside of work Iain enjoys spending time with family, skiing and hiking with his black Labrador Zara.